The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, Ph.D., FAAN, with contributions by experts from the Neurology journals, Neurology Today, Continuum, and more.
…
continue reading
1
Global Burden of Neurologic Conditions
2:53
2:53
Spela senare
Spela senare
Listor
Gilla
Gillad
2:53
Dr. Farrah Mateen and Dr. Katrin Seeher discuss the significant global burden of neurologic conditions, which affects over 3.4 billion people worldwide, and the strategies the WHO is implementing to improve care and awareness. Show reference: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00038-3/fulltext#seccestitle10…
…
continue reading
1
Deep Brain Stimulation of Symptom-Specific Networks in Parkinson Disease - Part 1
2:11
2:11
Spela senare
Spela senare
Listor
Gilla
Gillad
2:11
Drs. Jeff Ratliff, Nanditha Rajamani, and Andy Horn discuss what this study taught us about the use of deep brain stimulation when taking into account certain white matter tracts associated with key clinical Parkinson motor symptoms. Show reference: https://www.nature.com/articles/s41467-024-48731-1Av American Academy of Neurology
…
continue reading
Dr. Stacey Clardy discusses the importance of iron and ferritin in neurology in this lab minute. Show reference: https://ard.bmj.com/content/74/1/14aAv American Academy of Neurology
…
continue reading
1
What Neurologist Should Know About Antidepressants, Weight Gain for Neuropathy
2:32
2:32
Spela senare
Spela senare
Listor
Gilla
Gillad
2:32
Dr. Rae Bacharach discusses the Neurology Today article, "What Neurologist Should Know About Antidepressants, Weight Gain for Neuropathy" by Gina Shaw, available in the September 19th issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/fulltext/2024/09190/what_neurologists_should_know_about.2…
…
continue reading
1
The Topic of Neurological Care for Transgender Patients - Part 3
5:30
5:30
Spela senare
Spela senare
Listor
Gilla
Gillad
5:30
In the final part of this three-part series, Dr. Halley Alexander and Dr. Gwen Zeigler discuss the management of epilepsy in transgender or gender diverse patients. Show reference: https://www.neurology.org/doi/abs/10.1212/CPJ.0000000000200332Av American Academy of Neurology
…
continue reading
1
Relapsing-Remitting Immunotherapy Responsive SFN
4:21
4:21
Spela senare
Spela senare
Listor
Gilla
Gillad
4:21
Dr. Shuvro Roy and Dr. Anne Louise Oaklander discuss the big-picture takeaways for clinicians in the context of managing small-fiber neuropathy. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200286Av American Academy of Neurology
…
continue reading
1
Gender Discrepancies in Leadership Roles and Recognition Awards in the Child Neurology Society
2:25
2:25
Spela senare
Spela senare
Listor
Gilla
Gillad
2:25
Dr. Dara Albert and Dr. Jaclyn M. Martindale discuss the differences in gender representation among leadership positions and award recipients within the Child Neurology Society. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209746Av American Academy of Neurology
…
continue reading
1
The Topic of Neurological Care for Transgender Patients - Part 2
4:22
4:22
Spela senare
Spela senare
Listor
Gilla
Gillad
4:22
In part two of this three-part series, Dr. Halley Alexander and Dr. Gwen Zeigler discuss cerebrovascular risk and management in transgender and gender-diverse patients. Show reference: https://www.neurology.org/doi/abs/10.1212/CPJ.0000000000200332Av American Academy of Neurology
…
continue reading
1
The Topic of Neurological Care for Transgender Patients - Part 1
4:19
4:19
Spela senare
Spela senare
Listor
Gilla
Gillad
4:19
In part one of this three-part series, Dr. Halley Alexander and Dr. Gwen Zeigler discuss the crucial aspects about managing headaches in transgender and gender-diverse patients. Show reference: https://www.neurology.org/doi/abs/10.1212/CPJ.0000000000200332Av American Academy of Neurology
…
continue reading
1
A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders - Part 2
2:21
2:21
Spela senare
Spela senare
Listor
Gilla
Gillad
2:21
In part two of this two-part series, Drs. Jeff Ratliff, Michiko K. Bruno, and Lawrence Golbe discuss essential advice for general neurologists who suspect a patient might have an atypical disorder. Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200345Av American Academy of Neurology
…
continue reading
1
A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders - Part 1
3:23
3:23
Spela senare
Spela senare
Listor
Gilla
Gillad
3:23
In part one of this two-part series, Drs. Jeff Ratliff, Michiko K. Bruno, and Lawrence Golbe discuss practical tips for recognizing when a patient’s response to levodopa may indicate the need for an alternate diagnosis. Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200345
…
continue reading
1
CMAP and Myosin-Loss Pathology in Patients With Critical Illness Myopathy
1:50
1:50
Spela senare
Spela senare
Listor
Gilla
Gillad
1:50
Drs. Gordon Smith, Shahar Shelly, and Teerin Liewluck discuss the correlation between CMAP duration and myosin loss and their effect on mortality by comparing between patients with CIM with and without myosin loss. Show references: https://www.neurology.org/doi/10.1212/WNL.0000000000209496Av American Academy of Neurology
…
continue reading
1
Improving Clinical Documentation Efficiency with AI
2:20
2:20
Spela senare
Spela senare
Listor
Gilla
Gillad
2:20
Dr. Irfan Sheikh explores a newly released NeuroByte episode, providing an insightful overview of how AI technologies, including ambient intelligence, can streamline documentation processes and enhance the efficiency of clinical practices. Show references: https://learning.aan.com/courses/74256Av American Academy of Neurology
…
continue reading
1
Monoclonal Antibody to PACAP for Migraine Prevention - Part 2
4:00
4:00
Spela senare
Spela senare
Listor
Gilla
Gillad
4:00
In the second installment of this two-part series, Dr. Tesha Monteith and Dr. Messoud Ashina discuss the results of the phase two study on monoclonal antibody to PACAP for migraine prevention. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2314577Av American Academy of Neurology
…
continue reading
1
Depression During Intern Year Increases Risk for Persistent MD Depression: What Can Training Programs Do to Intervene
3:09
3:09
Spela senare
Spela senare
Listor
Gilla
Gillad
3:09
Dr. Rae Bacharach discusses the Neurology Today article, "Depression During Intern Year Increases Risk for Persistent MD Depression: What Can Training Programs Do to Intervene?" by Gina Shaw, available in the September 5th issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/fulltext/2024/0905…
…
continue reading
1
Monoclonal Antibody to PACAP for Migraine Prevention - Part 1
4:54
4:54
Spela senare
Spela senare
Listor
Gilla
Gillad
4:54
In the first installment of this two-part series, Dr. Tesha Monteith and Dr. Messoud Ashina explore the biology of PACAP, its significance in relation to migraines, and its potential as a novel therapeutic approach. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2314577Av American Academy of Neurology
…
continue reading
1
Association of Extent of TSS With Cerebral Glymphatic Clearance in Patients With IIH
2:07
2:07
Spela senare
Spela senare
Listor
Gilla
Gillad
2:07
Dr. Amy Gelfand and Dr. Matthew Bender discuss the possible association between glymphatic outflow and extent of TSS in patients with IIH. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209529
…
continue reading
1
Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome
1:55
1:55
Spela senare
Spela senare
Listor
Gilla
Gillad
1:55
Dr. Tesha Monteith discusses the Neurology article, "Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome: Results From the Randomized PRODROME Trial" by Richard B. Lipton and colleagues, available in the September 24th issue of Neurology or at neurology.org. Show reference: https://www.neurology.org/doi/…
…
continue reading
1
Large Study Finds COVID Vaccination Does Not Increase Multiple Sclerosis Relapses
2:44
2:44
Spela senare
Spela senare
Listor
Gilla
Gillad
2:44
Dr. Rae Bacharach discusses the Neurology Today article, "Large Study Finds COVID Vaccination Does Not Increase Multiple Sclerosis Relapses" by Susan FitzGerald, available in the September 5th issue of Neurology Today or at neurologytoday.com. Show reference: https://journals.lww.com/neurotodayonline/fulltext/2024/09050/large_study_finds_covid_vacc…
…
continue reading
1
Spinal Muscular Atrophy Update in Best Practices - Part 3
1:33
1:33
Spela senare
Spela senare
Listor
Gilla
Gillad
1:33
In the third episode of this three-part series, Dr. Stacey Clardy and Dr. Mary Schroth discuss the critical objective of advancing the quality of life for individuals with SMA in the coming years. Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200310Av American Academy of Neurology
…
continue reading
1
Specialist Physiotherapy for Functional Motor Disorder
1:42
1:42
Spela senare
Spela senare
Listor
Gilla
Gillad
1:42
Dr. David Perez and Dr. Glenn Nielsen discuss the effectiveness of physiotherapy in treating functional motor disorder and to determine the best approach for physiotherapy treatment. Show reference: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(24)00135-2/fulltextAv American Academy of Neurology
…
continue reading
1
Spinal Muscular Atrophy Update in Best Practices - Part 2
1:59
1:59
Spela senare
Spela senare
Listor
Gilla
Gillad
1:59
In the second episode of this three-part series, Dr. Stacey Clardy and Dr. Mary Schroth discuss the currently available treatments for spinal muscular atrophy. Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200310Av American Academy of Neurology
…
continue reading
1
Spinal Muscular Atrophy Update in Best Practice - Part 1
3:07
3:07
Spela senare
Spela senare
Listor
Gilla
Gillad
3:07
In the first episode of this three-part series, Dr. Stacey Clardy and Dr. Mary Schroth discuss the most common types of spinal muscular atrophy. Show reference: https://www.neurology.org/doi/full/10.1212/CPJ.0000000000200310Av American Academy of Neurology
…
continue reading
1
Blood Biomarkers to Detect Alzheimer Disease - Part 2
1:47
1:47
Spela senare
Spela senare
Listor
Gilla
Gillad
1:47
In part two of this series, Dr. Gregg Day and Dr. Sebastian Palmqvist discuss how this new blood test can enhance the accuracy of diagnosing Alzheimer’s disease in patients with cognitive symptoms. Show reference: https://jamanetwork.com/journals/jama/fullarticle/2821669Av American Academy of Neurology
…
continue reading
1
Outcomes of Patients With MCI With Lewy Bodies or Alzheimer Disease - Part 2
1:38
1:38
Spela senare
Spela senare
Listor
Gilla
Gillad
1:38
In the second part of this two-part series, Dr. Jeff Ratliff and Dr. Calum Hamilton discuss the clinical criteria that listeners should look out for, indicating a subtype of mild cognitive impairment known as DLB, which could potentially progress into a full dementia with Lewy body phenotype. Show reference: https://www.neurology.org/doi/10.1212/WN…
…
continue reading